In liver cancer cells, treatment with corosolic acid or inhibition of CDK19, a kinase that regulates proliferation in various cancers, results in reduced O-GlcNAc level and reduced expression of OGT and Yap ultimately leading to impaired cell proliferation as well as defective tumor growth (115). Here, OGT is linked to liver cancer.